Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Molloy

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
AIDS (London, England)|August 14, 2018
Effect of oral fluconazole 1200 mg/day on QT interval in African adults with HIV-associated cryptococcal meningitisSíle F Molloy, John Bradley, Natasha Karunaharan, et al.
European Journal of Neurology|September 21, 2016
Epidemiological, clinical and genetic aspects of adult onset isolated focal dystonia in IrelandL Williams, E McGovern, O Kimmich, et al.
Wellcome Open Research|May 15, 2026
Ophthalmic features of HIV associated cryptococcal meningitis in Malawian Adults: an observational studyJayne P Ellis, Kate Gaskell, Mary Peirse, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2019
One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in MalawiCecilia Kanyama, Síle F Molloy, Adrienne K Chan, et al.
Journal of Clinical Microbiology|October 22, 2020
Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV DiseaseMark W Tenforde, Timothée Boyer-Chammard, Charles Muthoga, et al.
Journal of Clinical Microbiology|May 29, 2020
Evaluation of a Novel Semiquantitative Cryptococcal Antigen Lateral Flow Assay in Patients with Advanced HIV DiseaseJoseph N Jarvis, Mark W Tenforde, Kwana Lechiile, et al.
AIDS (London, England)|June 27, 2020
A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and durationMelanie Alufandika, David S Lawrence, Timothée Boyer-Chammard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2019
Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan AfricaTao Chen, Lawrence Mwenge, Shabir Lakhi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2018
Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled TrialJoseph N Jarvis, Tshepo B Leeme, Mooketsi Molefi, et al.
Mbio|November 10, 2022
Genomic Variation across a Clinical Cryptococcus Population Linked to Disease OutcomePoppy Sephton-Clark, Jennifer L Tenor, Dena L Toffaletti, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|August 14, 2018
Effect of oral fluconazole 1200 mg/day on QT interval in African adults with HIV-associated cryptococcal meningitisSíle F Molloy, John Bradley, Natasha Karunaharan, et al.
European Journal of Neurology|September 21, 2016
Epidemiological, clinical and genetic aspects of adult onset isolated focal dystonia in IrelandL Williams, E McGovern, O Kimmich, et al.
Wellcome Open Research|May 15, 2026
Ophthalmic features of HIV associated cryptococcal meningitis in Malawian Adults: an observational studyJayne P Ellis, Kate Gaskell, Mary Peirse, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2019
One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in MalawiCecilia Kanyama, Síle F Molloy, Adrienne K Chan, et al.
Journal of Clinical Microbiology|October 22, 2020
Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV DiseaseMark W Tenforde, Timothée Boyer-Chammard, Charles Muthoga, et al.
Journal of Clinical Microbiology|May 29, 2020
Evaluation of a Novel Semiquantitative Cryptococcal Antigen Lateral Flow Assay in Patients with Advanced HIV DiseaseJoseph N Jarvis, Mark W Tenforde, Kwana Lechiile, et al.
AIDS (London, England)|June 27, 2020
A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and durationMelanie Alufandika, David S Lawrence, Timothée Boyer-Chammard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2019
Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan AfricaTao Chen, Lawrence Mwenge, Shabir Lakhi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2018
Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled TrialJoseph N Jarvis, Tshepo B Leeme, Mooketsi Molefi, et al.
Mbio|November 10, 2022
Genomic Variation across a Clinical Cryptococcus Population Linked to Disease OutcomePoppy Sephton-Clark, Jennifer L Tenor, Dena L Toffaletti, et al.
Pageof 7